Northera (Lundbeck Pharmaceuticals LLC)
Welcome to the PulseAid listing for the Northera drug offered from Lundbeck Pharmaceuticals LLC. This Catecholamines [Chemical/Ingredient],Increased Blood Pressure [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Lundbeck Pharmaceuticals LLC |
NON-PROPRIETARY NAME: | droxidopa |
SUBSTANCE NAME: | DROXIDOPA |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Catecholamines [Chemical/Ingredient],Increased Blood Pressure [PE] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2014-09-01 |
END MARKETING DATE: | 0000-00-00 |
Northera HUMAN PRESCRIPTION DRUG Details:
Item Description | Northera from Lundbeck Pharmaceuticals LLC |
LABELER NAME: | Lundbeck Pharmaceuticals LLC |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 100(mg/1) |
START MARKETING DATE: | 2014-09-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 67386-820_ccb12992-471d-4622-bb31-4fe70a08d4ec |
PRODUCT NDC: | 67386-820 |
APPLICATION NUMBER: | NDA203202 |
Other DROXIDOPA Pharmaceutical Manufacturers / Labelers: